Source: Eur Respir J 2009; 34: 1018-1023
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Keene O. N., Vestbo J., Anderson J. A., Calverley P. M. A., Celli B., Ferguson G. T., Jenkins C., Jones P. W.. Methods for therapeutic trials in COPD: lessons from the TORCH trial. Eur Respir J 2009; 34: 1018-1023

Member's Comments

No comment yet.

Related content which might interest you: Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 A randomised controlled trial of individualised, progressed early exercise in patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015 Premature discontinuation of patients: a potential bias in COPD clinical trials Source: Eur Respir J 2007; 30: 898-906 Year: 2007 Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2008; 31: 927-933 Year: 2008 A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT) Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2015 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 903-908 Year: 2001 Telerehabilitation in people with chronic obstructive pulmonary disease (COPD): A randomised controlled trial Source: International Congress 2016 – Best abstracts in physical activity and telemedicine Year: 2016 Prevention of exacerbations of COPD with pharmacotherapy Source: Eur Respir Rev 2009; 19: 119-126 Year: 2010 Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations Source: Eur Respir J 2003; 21: 68-73 Year: 2003 Exacerbations and associated health-care cost in patients with chronic obstructive pulmonary disease (COPD) in general practice. Results from the COOPT trial Source: Eur Respir J 2002; 20: Suppl. 38, 398s Year: 2002 Measurement properties of exacerbations of chronic pulmonary disease tool (EXACT) in a clinical trial of patients with moderate to severe COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Greatest International ANti-infective Trial (GIANT) – the German cohort: moxifloxacin treatment provides short- and long-term benefits in AECB patients Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Comorbidities in chronic obstructive pulmonary disease - Results of a national multicenter research project Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations Source: Guideline 2022 Year: 2021 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005